Molecule ChEMBL ID;Compound Key;Smiles;Standard Type;Standard Value;Standard Units;Corrected;Assay Description;Target Name;Target Organism;Target Type;Document ChEMBL ID
CHEMBL3260990;ESI-09;CC(C)(C)c1cc(C(=O)/C(C#N)=N/Nc2cccc(Cl)c2)no1;Kd;99.0;nM;99.0;Displacement of dansylated phenylalanine from human serum albumin by fluorescence assay;Serum albumin;Homo sapiens;SINGLE PROTEIN;CHEMBL4396878
CHEMBL202798;79R;COc1cc(CCCN2CCOCC2)ccc1-c1ccc(C(=O)NS(=O)(=O)c2ccc(N[C@H](CCN(C)C)CSc3ccccc3)c([N+](=O)[O-])c2)cc1;Kd;94000.0;nM;94000.0;Binding affinity for human serum albumin domain III;Serum albumin;Homo sapiens;SINGLE PROTEIN;CHEMBL1149415
CHEMBL384757;FMS2-Gentamycin;CNC(C)[C@H]1CCC(N)[C@@H](O[C@@H]2C(NC(=O)OCC3c4ccccc4-c4ccc(S(=O)(=O)O)cc43)C[C@@H](NC(=O)OCC3c4ccccc4-c4ccc(S(=O)(=O)O)cc43)C(O[C@H]3OC[C@](C)(O)C(NC)[C@@H]3O)[C@@H]2O)O1;Kd;9200.0;nM;9200.0;The compound was evaluated for pharmacokinetic parameters Serum albumin associating affinity;Serum albumin;Homo sapiens;SINGLE PROTEIN;CHEMBL1135785
CHEMBL264831;FMS3-Gentamycin;CNC(C)[C@H]1CCC(NC(=O)OCC2c3ccccc3-c3ccc(S(=O)(=O)O)cc32)[C@@H](O[C@@H]2C(NC(=O)OCC3c4ccccc4-c4ccc(S(=O)(=O)O)cc43)C[C@@H](NC(=O)OCC3c4ccccc4-c4ccc(S(=O)(=O)O)cc43)C(O[C@H]3OC[C@](C)(O)C(NC)[C@@H]3O)[C@@H]2O)O1;Kd;9200.0;nM;9200.0;The compound was evaluated for albumin associating affinity along with 2.1 M of FMS;Serum albumin;Homo sapiens;SINGLE PROTEIN;CHEMBL1135785
CHEMBL81444;1;Cc1cc2c(C(C)C)c(O)c(O)c(C(=O)O)c2c(O)c1-c1c(C)cc2c(C(C)C)c(O)c(O)c(C(=O)O)c2c1O;Kd;90.0;nM;90.0;Compound was tested for binding activity to human serum albumin (HSA);Serum albumin;Homo sapiens;SINGLE PROTEIN;CHEMBL1128714
CHEMBL72;desipramine;CNCCCN1c2ccccc2CCc2ccccc21;Kd;851138.04;nM;851138.04;Binding affinity to human serum albumin by PAMPA method;Serum albumin;Homo sapiens;SINGLE PROTEIN;CHEMBL1144698
CHEMBL561947;Albu-acetazolamide;NS(=O)(=O)c1nnc(NC(=O)CCC(=O)NC(CCCCNC(=O)CCCc2ccc(I)cc2)C(=O)O)s1;Kd;820.0;nM;820.0;Binding affinity to HSA by isothermal titration calorimetry;Serum albumin;Homo sapiens;SINGLE PROTEIN;CHEMBL1154037
CHEMBL247241;11;COc1ccc(NC(=O)c2cccc(S(=O)(=O)N3CCOCC3)c2)c(C(=O)O)c1;Kd;8100.0;nM;8100.0;Displacement of fluorescent dansyl sarcosine from human serum albumin site II on subdomain IIIA;Serum albumin;Homo sapiens;SINGLE PROTEIN;CHEMBL1139792
CHEMBL3940890;AG10;Cc1n[nH]c(C)c1CCCOc1cc(C(=O)O)ccc1F;Kd;8000.0;nM;8000.0;Binding affinity to human serum albumin by ITC method;Serum albumin;Homo sapiens;SINGLE PROTEIN;CHEMBL4196168
CHEMBL596595;3a;CN(C)C1=NN(c2ccccc2)CN(c2ccccc2Cl)C1=O;Kd;7960.0;nM;7960.0;Binding affinity to HSA after 30 mins assessed as quenching of intrinsic HSA fluorescence emission by spectrofluorimetric assay;Serum albumin;Homo sapiens;SINGLE PROTEIN;CHEMBL1157585
CHEMBL941;imatinib;Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1;Kd;78640.0;nM;78640.0;Binding affinity to HSA after 30 mins assessed as quenching of intrinsic HSA fluorescence emission by spectrofluorimetric assay;Serum albumin;Homo sapiens;SINGLE PROTEIN;CHEMBL1157585
CHEMBL4569917;27;CCCCCCCCN(CCC(=O)Nc1ccccc1)CCC(=O)Nc1ccc(F)cc1;Kd;7800.0;nM;7800.0;Binding affinity to human serum albumin;Serum albumin;Homo sapiens;SINGLE PROTEIN;CHEMBL4359814
CHEMBL264831;FMS3-Gentamycin;CNC(C)[C@H]1CCC(NC(=O)OCC2c3ccccc3-c3ccc(S(=O)(=O)O)cc32)[C@@H](O[C@@H]2C(NC(=O)OCC3c4ccccc4-c4ccc(S(=O)(=O)O)cc43)C[C@@H](NC(=O)OCC3c4ccccc4-c4ccc(S(=O)(=O)O)cc43)C(O[C@H]3OC[C@](C)(O)C(NC)[C@@H]3O)[C@@H]2O)O1;Kd;7600.0;nM;7600.0;The compound was evaluated for albumin associating affinity along with 3.0 M of FMS;Serum albumin;Homo sapiens;SINGLE PROTEIN;CHEMBL1135785
CHEMBL247791;10;Cc1ccc(NC(=O)c2cccc(S(=O)(=O)N3CCOCC3)c2)c(C(=O)O)c1;Kd;7500.0;nM;7500.0;Displacement of fluorescent dansyl sarcosine from human serum albumin site II on subdomain IIIA;Serum albumin;Homo sapiens;SINGLE PROTEIN;CHEMBL1139792
CHEMBL10811;A;Cc1cc(C)c(S(=O)(=O)N[C@@H](Cc2ccc(-c3cccc(NC(=O)NC4CC4)c3)cc2)C(=O)O)c(C)c1;Kd;740.0;nM;740.0;Binding affinity to human serum albumin by equilibrium dialysis;Serum albumin;Homo sapiens;SINGLE PROTEIN;CHEMBL1140543
CHEMBL6;Indomethacin;COc1ccc2c(c1)c(CC(=O)O)c(C)n2C(=O)c1ccc(Cl)cc1;Kd;700.0;nM;700.0;Binding affinity to human serum albumin;Serum albumin;Homo sapiens;SINGLE PROTEIN;CHEMBL4017493
CHEMBL233625;12h;COCCOCCCSc1ccc(C(=O)Nc2ccc(C#N)cc2C(=O)O)cn1;Kd;700.0;nM;700.0;Binding affinity to human serum albumin;Serum albumin;Homo sapiens;SINGLE PROTEIN;CHEMBL1147948
CHEMBL568;oxazepam;O=C1Nc2ccc(Cl)cc2C(c2ccccc2)=NC1O;Kd;69183.1;nM;69183.1;Binding affinity to human serum albumin by PAMPA method;Serum albumin;Homo sapiens;SINGLE PROTEIN;CHEMBL1144698
CHEMBL335464;8;CC(C)c1csc(COc2ccn3c(=O)c(-c4nnn[nH]4)cnc3c2)n1;Kd;66400.0;nM;66400.0;Protein binding affinity for human serum albumin was measured;Serum albumin;Homo sapiens;SINGLE PROTEIN;CHEMBL1136458
CHEMBL27;propranolol;CC(C)NCC(O)COc1cccc2ccccc12;Kd;660693.45;nM;660693.45;Binding affinity to 100 uM human serum albumin at 10 uM by PAMPA method;Serum albumin;Homo sapiens;SINGLE PROTEIN;CHEMBL1144698
CHEMBL247242;12;O=C(Nc1ccc(F)cc1C(=O)O)c1cccc(S(=O)(=O)N2CCOCC2)c1;Kd;6600.0;nM;6600.0;Displacement of fluorescent dansyl sarcosine from human serum albumin site II on subdomain IIIA;Serum albumin;Homo sapiens;SINGLE PROTEIN;CHEMBL1139792
CHEMBL77613;5;Cc1ccc2c(C=O)c(O)c(O)c(C(C)C)c2c1;Kd;660.0;nM;660.0;Compound was tested for binding activity to human serum albumin (HSA);Serum albumin;Homo sapiens;SINGLE PROTEIN;CHEMBL1128714
CHEMBL247794;13;O=C(Nc1ccc(Cl)cc1C(=O)O)c1cccc(S(=O)(=O)N2CCOCC2)c1;Kd;6500.0;nM;6500.0;Displacement of fluorescent dansyl sarcosine from human serum albumin site II on subdomain IIIA;Serum albumin;Homo sapiens;SINGLE PROTEIN;CHEMBL1139792
CHEMBL6966;verapamil;COc1ccc(CCN(C)CCCC(C#N)(c2ccc(OC)c(OC)c2)C(C)C)cc1OC;Kd;645654.23;nM;645654.23;Binding affinity to human serum albumin by PAMPA method;Serum albumin;Homo sapiens;SINGLE PROTEIN;CHEMBL1144698
CHEMBL27;propranolol;CC(C)NCC(O)COc1cccc2ccccc12;Kd;630957.34;nM;630957.34;Binding affinity to 600 uM human serum albumin at 10 uM by PAMPA method;Serum albumin;Homo sapiens;SINGLE PROTEIN;CHEMBL1144698
CHEMBL27;propranolol;CC(C)NCC(O)COc1cccc2ccccc12;Kd;602559.59;nM;602559.59;Binding affinity to 300 uM human serum albumin at 10 uM by PAMPA method;Serum albumin;Homo sapiens;SINGLE PROTEIN;CHEMBL1144698
CHEMBL782;tolbutamide;CCCCNC(=O)NS(=O)(=O)c1ccc(C)cc1;Kd;6025.6;nM;6025.6;Binding affinity to human serum albumin by PAMPA method;Serum albumin;Homo sapiens;SINGLE PROTEIN;CHEMBL1144698
CHEMBL249879;9;O=C(Nc1ccccc1C(=O)O)c1cccc(S(=O)(=O)N2CCOCC2)c1;Kd;6000.0;nM;6000.0;Displacement of fluorescent dansyl sarcosine from human serum albumin site II on subdomain IIIA;Serum albumin;Homo sapiens;SINGLE PROTEIN;CHEMBL1139792
CHEMBL473417;vismodegib, GDC-0449;CS(=O)(=O)c1ccc(C(=O)Nc2ccc(Cl)c(-c3ccccn3)c2)c(Cl)c1;Kd;6000.0;nM;6000.0;Binding affinity to low-affinity binding site of human serum albumin at 20 degC by surface plasmon resonance assay;Serum albumin;Homo sapiens;SINGLE PROTEIN;CHEMBL1772967
CHEMBL269277;1, Betulinic acid;C=C(C)[C@@H]1CC[C@]2(C(=O)O)CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CC[C@H](O)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]12;Kd;593.0;nM;593.0;Binding affinity to human serum albumin with excitation at 285 nm by fluorescence emission spectroscopic analysis;Serum albumin;Homo sapiens;SINGLE PROTEIN;CHEMBL3600335
CHEMBL473417;vismodegib, GDC-0449;CS(=O)(=O)c1ccc(C(=O)Nc2ccc(Cl)c(-c3ccccn3)c2)c(Cl)c1;Kd;5500.0;nM;5500.0;Binding affinity to human serum albumin at 20 degC by isothermal titration calorimetry analysis;Serum albumin;Homo sapiens;SINGLE PROTEIN;CHEMBL1772967
CHEMBL71;chlorpromazine;CN(C)CCCN1c2ccccc2Sc2ccc(Cl)cc21;Kd;54954.09;nM;54954.09;Binding affinity to human serum albumin by PAMPA method;Serum albumin;Homo sapiens;SINGLE PROTEIN;CHEMBL1144698
CHEMBL1464;warfarin;CC(=O)CC(c1ccccc1)c1c(O)c2ccccc2oc1=O;Kd;5400.0;nM;5400.0;Binding affinity to low-affinity binding site of human serum albumin at 20 degC by surface plasmon resonance assay;Serum albumin;Homo sapiens;SINGLE PROTEIN;CHEMBL1772967
CHEMBL249674;6;N#Cc1ccc(NC(=O)c2ccc(S(=O)(=O)N3CCOCC3)cc2)c(C(=O)O)c1;Kd;5300.0;nM;5300.0;Displacement of fluorescent dansyl sarcosine from human serum albumin site II on subdomain IIIA;Serum albumin;Homo sapiens;SINGLE PROTEIN;CHEMBL1139792
CHEMBL310405;6;Cc1ccc2c(C(=O)O)c(O)c(O)c(C(C)C)c2c1;Kd;5280.0;nM;5280.0;Compound was tested for binding activity to human serum albumin (HSA);Serum albumin;Homo sapiens;SINGLE PROTEIN;CHEMBL1128714
CHEMBL1464;warfarin;CC(=O)CC(c1ccccc1)c1c(O)c2ccccc2oc1=O;Kd;510000.0;nM;510000.0;Binding affinity to high-affinity binding site of human serum albumin at 20 degC by surface plasmon resonance assay;Serum albumin;Homo sapiens;SINGLE PROTEIN;CHEMBL1772967
CHEMBL247795;14;O=C(Nc1ccc(Br)cc1C(=O)O)c1cccc(S(=O)(=O)N2CCOCC2)c1;Kd;4800.0;nM;4800.0;Displacement of fluorescent dansyl sarcosine from human serum albumin site II on subdomain IIIA;Serum albumin;Homo sapiens;SINGLE PROTEIN;CHEMBL1139792
CHEMBL3601025;2;C=C(C)[C@@H]1CC[C@]2(C(=O)N[C@H](C)C(=O)[O-])CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CC[C@H](O)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]12.C[N+](C)(C)CCO;Kd;47000.0;nM;47000.0;Binding affinity to human serum albumin with excitation at 285 nm after 30 mins by fluorescence spectrophotometric analysis;Serum albumin;Homo sapiens;SINGLE PROTEIN;CHEMBL3600335
CHEMBL1464;warfarin;CC(=O)CC(c1ccccc1)c1c(O)c2ccccc2oc1=O;Kd;4677.35;nM;4677.35;Binding affinity to human serum albumin by PAMPA method;Serum albumin;Homo sapiens;SINGLE PROTEIN;CHEMBL1144698
CHEMBL269277;1, Betulinic acid;C=C(C)[C@@H]1CC[C@]2(C(=O)O)CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CC[C@H](O)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]12;Kd;4500.0;nM;4500.0;Binding affinity to human serum albumin with excitation at 285 nm after 30 mins by fluorescence spectrophotometric analysis;Serum albumin;Homo sapiens;SINGLE PROTEIN;CHEMBL3600335
CHEMBL853;Zalcitabine;Nc1ccn([C@H]2CC[C@@H](CO)O2)c(=O)n1;Kd;44000.0;nM;44000.0;Binding affinity to human serum albumin with excitation at 280 nm after 2 hrs by spectrofluorimetric analysis;Serum albumin;Homo sapiens;SINGLE PROTEIN;CHEMBL3600335
CHEMBL1460;didanosine;O=c1[nH]cnc2c1ncn2[C@H]1CC[C@@H](CO)O1;Kd;44000.0;nM;44000.0;Binding affinity to human serum albumin with excitation at 280 nm after 2 hrs by spectrofluorimetric analysis;Serum albumin;Homo sapiens;SINGLE PROTEIN;CHEMBL3600335
CHEMBL129;AZT;Cc1cn([C@H]2C[C@H](N=[N+]=[N-])[C@@H](CO)O2)c(=O)[nH]c1=O;Kd;44000.0;nM;44000.0;Binding affinity to human serum albumin with excitation at 280 nm after 2 hrs by spectrofluorimetric analysis;Serum albumin;Homo sapiens;SINGLE PROTEIN;CHEMBL3600335
CHEMBL885;emtricitabine;Nc1nc(=O)n([C@@H]2CS[C@H](CO)O2)cc1F;Kd;44000.0;nM;44000.0;Binding affinity to human serum albumin with excitation at 280 nm after 2 hrs by spectrofluorimetric analysis;Serum albumin;Homo sapiens;SINGLE PROTEIN;CHEMBL3600335
CHEMBL991;stavudine;Cc1cn([C@H]2C=C[C@@H](CO)O2)c(=O)[nH]c1=O;Kd;44000.0;nM;44000.0;Binding affinity to human serum albumin with excitation at 280 nm after 2 hrs by spectrofluorimetric analysis;Serum albumin;Homo sapiens;SINGLE PROTEIN;CHEMBL3600335
CHEMBL1380;ABC;Nc1nc(NC2CC2)c2ncn([C@H]3C=C[C@@H](CO)C3)c2n1;Kd;44000.0;nM;44000.0;Binding affinity to human serum albumin with excitation at 280 nm after 2 hrs by spectrofluorimetric analysis;Serum albumin;Homo sapiens;SINGLE PROTEIN;CHEMBL3600335
CHEMBL141;3TC;Nc1ccn([C@@H]2CS[C@H](CO)O2)c(=O)n1;Kd;44000.0;nM;44000.0;Binding affinity to human serum albumin with excitation at 280 nm after 2 hrs by spectrofluorimetric analysis;Serum albumin;Homo sapiens;SINGLE PROTEIN;CHEMBL3600335
CHEMBL395703;15;O=C(Nc1ccc([N+](=O)[O-])cc1C(=O)O)c1cccc(S(=O)(=O)N2CCOCC2)c1;Kd;4400.0;nM;4400.0;Displacement of fluorescent dansyl sarcosine from human serum albumin site II on subdomain IIIA;Serum albumin;Homo sapiens;SINGLE PROTEIN;CHEMBL1139792
CHEMBL27;propranolol;CC(C)NCC(O)COc1cccc2ccccc12;Kd;436515.83;nM;436515.83;Binding affinity to human serum albumin by PAMPA method;Serum albumin;Homo sapiens;SINGLE PROTEIN;CHEMBL1144698
CHEMBL27;propranolol;CC(C)NCC(O)COc1cccc2ccccc12;Kd;436515.83;nM;436515.83;Binding affinity to 100 uM human serum albumin at 50 uM by PAMPA method;Serum albumin;Homo sapiens;SINGLE PROTEIN;CHEMBL1144698
CHEMBL249990;10;Cc1cc(C)c(S(=O)(=O)N[C@@H](Cc2ccc(-c3cccc(Nc4c(NC5CC5)c(=O)c4=O)c3)cc2)C(=O)O)c(C)c1;Kd;420.0;nM;420.0;Binding affinity to human serum albumin by equilibrium dialysis;Serum albumin;Homo sapiens;SINGLE PROTEIN;CHEMBL1140543
CHEMBL3244575;11;O=C(O)c1cccc(F)c1O;Kd;41800.0;nM;41800.0;Binding affinity to human serum albumin by NMR spectroscopy;Serum albumin;Homo sapiens;SINGLE PROTEIN;CHEMBL4368900
CHEMBL3244575;11;O=C(O)c1cccc(F)c1O;Kd;41000.0;nM;41000.0;Binding affinity to human serum albumin by ITC;Serum albumin;Homo sapiens;SINGLE PROTEIN;CHEMBL4368900
CHEMBL3601028;5;C=C(C)[C@@H]1CC[C@]2(C(=O)[O-])CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CC[C@H](O)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]12.C[N+](C)(C)CCO;Kd;4000.0;nM;4000.0;Binding affinity to human serum albumin with excitation at 295 nm after 30 mins by fluorescence spectrophotometric analysis;Serum albumin;Homo sapiens;SINGLE PROTEIN;CHEMBL3600335
CHEMBL3601028;5;C=C(C)[C@@H]1CC[C@]2(C(=O)[O-])CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CC[C@H](O)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]12.C[N+](C)(C)CCO;Kd;3900.0;nM;3900.0;Binding affinity to human serum albumin with excitation at 285 nm after 30 mins by fluorescence spectrophotometric analysis;Serum albumin;Homo sapiens;SINGLE PROTEIN;CHEMBL3600335
CHEMBL249022;6;Cn1c(/C=C/c2ccc(C#N)cc2C(=O)O)cc2ccccc21;Kd;390.03;nM;390.03;Binding affinity at human serum albumin;Serum albumin;Homo sapiens;SINGLE PROTEIN;CHEMBL1140642
CHEMBL504510;5;O=C(O)CCCCCOc1ccc(/C=C/c2cc(O)cc(O)c2)cc1;Kd;382.0;nM;382.0;Binding affinity to human serum albumin at 4 uM by UV-vis measurement;Serum albumin;Homo sapiens;SINGLE PROTEIN;CHEMBL1150416
CHEMBL3601025;2;C=C(C)[C@@H]1CC[C@]2(C(=O)N[C@H](C)C(=O)[O-])CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CC[C@H](O)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]12.C[N+](C)(C)CCO;Kd;37000.0;nM;37000.0;Binding affinity to human serum albumin with excitation at 295 nm after 30 mins by fluorescence spectrophotometric analysis;Serum albumin;Homo sapiens;SINGLE PROTEIN;CHEMBL3600335
CHEMBL27;Propranolol;CC(C)NCC(O)COc1cccc2ccccc12;Kd;354813.39;nM;354813.39;Binding affinity to 50 uM human serum albumin at 10 uM by PAMPA method;Serum albumin;Homo sapiens;SINGLE PROTEIN;CHEMBL1144698
CHEMBL335261;10;CC(C)c1csc(CCc2ccn3c(=O)c(-c4nnn[nH]4)cnc3c2)n1;Kd;327000.0;nM;327000.0;Protein binding affinity for human serum albumin was measured;Serum albumin;Homo sapiens;SINGLE PROTEIN;CHEMBL1136458
CHEMBL2180871;11;CC[C@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)N[C@@H](CCCCN)C(=O)NCCCCN=[N+]=[N-])C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C(=O)N[C@H]1CSSC[C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc2c[nH]c3ccccc23)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)O)NC(=O)CNC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]2CCCN2C(=O)[C@H](CC(C)C)NC1=O)[C@@H](C)CC;Kd;321.0;nM;321.0;Binding affinity to human serum albumin by fluorescence polarization assay;Serum albumin;Homo sapiens;SINGLE PROTEIN;CHEMBL2177015
CHEMBL264831;FMS3-Gentamycin;CNC(C)[C@H]1CCC(NC(=O)OCC2c3ccccc3-c3ccc(S(=O)(=O)O)cc32)[C@@H](O[C@@H]2C(NC(=O)OCC3c4ccccc4-c4ccc(S(=O)(=O)O)cc43)C[C@@H](NC(=O)OCC3c4ccccc4-c4ccc(S(=O)(=O)O)cc43)C(O[C@H]3OC[C@](C)(O)C(NC)[C@@H]3O)[C@@H]2O)O1;Kd;32000.0;nM;32000.0;The compound was evaluated for albumin associating affinity 0.7 M of FMS;Serum albumin;Homo sapiens;SINGLE PROTEIN;CHEMBL1135785
CHEMBL170;quinine;C=C[C@H]1CN2CC[C@H]1C[C@H]2[C@H](O)c1ccnc2ccc(OC)cc12;Kd;309029.54;nM;309029.54;Binding affinity to human serum albumin by PAMPA method;Serum albumin;Homo sapiens;SINGLE PROTEIN;CHEMBL1144698
CHEMBL4459845;5;CCCCCCCCN(CCC(=O)Nc1ccccc1)CCC(=O)NC1CCCCC1;Kd;3000.0;nM;3000.0;Binding affinity to human serum albumin;Serum albumin;Homo sapiens;SINGLE PROTEIN;CHEMBL4359814
CHEMBL82428;2;CC(=N)c1c(O)c(O)c(C(C)C)c2cc(C)c(-c3c(C)cc4c(C(C)C)c(O)c(O)c(C(C)=N)c4c3O)c(O)c12;Kd;3000.0;nM;3000.0;Compound was tested for binding activity to human serum albumin (HSA);Serum albumin;Homo sapiens;SINGLE PROTEIN;CHEMBL1128714
CHEMBL898;Diflunisal;O=C(O)c1cc(-c2ccc(F)cc2F)ccc1O;Kd;3000.0;nM;3000.0;Binding affinity to human serum albumin;Serum albumin;Homo sapiens;SINGLE PROTEIN;CHEMBL4017493
CHEMBL4443226;"3; UCM-1336";CCCCCCCCN(CCC(=O)Nc1ccccc1)CCC(=O)Nc1ccccc1;Kd;28000.0;nM;28000.0;Binding affinity to human serum albumin;Serum albumin;Homo sapiens;SINGLE PROTEIN;CHEMBL4359814
CHEMBL337637;1;CC(C)c1csc(/C=C/c2cccc(NC(=O)Cc3ccccc3C(=O)O)c2)n1;Kd;280.0;nM;280.0;Protein binding affinity for human serum albumin was measured;Serum albumin;Homo sapiens;SINGLE PROTEIN;CHEMBL1136458
CHEMBL611366;3d;O=C1C(N2CCCC2)=NN(c2ccc(Cl)cc2)CN1c1ccccc1Cl;Kd;2770.0;nM;2770.0;Binding affinity to HSA after 30 mins assessed as quenching of intrinsic HSA fluorescence emission by spectrofluorimetric assay;Serum albumin;Homo sapiens;SINGLE PROTEIN;CHEMBL1157585
CHEMBL3353611;9a;N=C(N)NCCCCCCCCNCCCCCCCCNC(=N)NCC1CC1.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F;Kd;26520.0;nM;26520.0;Binding affinity to human serum albumin after 30 mins by fluorescence spectroscopic analysis;Serum albumin;Homo sapiens;SINGLE PROTEIN;CHEMBL3352312
CHEMBL2103837;Tafamidis;O=C(O)c1ccc2nc(-c3cc(Cl)cc(Cl)c3)oc2c1;Kd;2500.0;nM;2500.0;Binding affinity to human serum albumin;Serum albumin;Homo sapiens;SINGLE PROTEIN;CHEMBL4196168
CHEMBL596797;3c;O=C1C(N2CCCC2)=NN(c2ccccc2)CN1c1ccccc1Cl;Kd;2460.0;nM;2460.0;Binding affinity to HSA after 30 mins assessed as quenching of intrinsic HSA fluorescence emission by spectrofluorimetric assay;Serum albumin;Homo sapiens;SINGLE PROTEIN;CHEMBL1157585
CHEMBL12;diazepam;CN1C(=O)CN=C(c2ccccc2)c2cc(Cl)ccc21;Kd;24547.09;nM;24547.09;Binding affinity to human serum albumin by PAMPA method;Serum albumin;Homo sapiens;SINGLE PROTEIN;CHEMBL1144698
CHEMBL139;diclofenac;O=C(O)Cc1ccccc1Nc1c(Cl)cccc1Cl;Kd;2454.71;nM;2454.71;Binding affinity to human serum albumin by PAMPA method;Serum albumin;Homo sapiens;SINGLE PROTEIN;CHEMBL1144698
CHEMBL4438023;2;N=C(N)NCCCCCCCCN(CCCCCCCCNC(=N)NCC1CC1)C(=O)N(CCCCCCCCNC(=N)N)CCCCCCCCNC(=N)NCC1CC1;Kd;23270.0;nM;23270.0;Binding affinity to human serum albumin assessed as dissociation constant after 30 mins by fluorescence-based assay;Serum albumin;Homo sapiens;SINGLE PROTEIN;CHEMBL4308851
CHEMBL2103837;Tafamidis;O=C(O)c1ccc2nc(-c3cc(Cl)cc(Cl)c3)oc2c1;Kd;2300.0;nM;2300.0;Binding affinity to human serum albumin by ITC method;Serum albumin;Homo sapiens;SINGLE PROTEIN;CHEMBL4196168
CHEMBL3260990;ESI-09;CC(C)(C)c1cc(C(=O)/C(C#N)=N/Nc2cccc(Cl)c2)no1;Kd;230.0;nM;230.0;Displacement of dansylated arginine from human serum albumin by fluorescence assay;Serum albumin;Homo sapiens;SINGLE PROTEIN;CHEMBL4396878
CHEMBL135682;6;CC(C)c1csc(/C=C/c2ccn3c(=O)c(-c4nnn[nH]4)cnc3c2)n1;Kd;22000.0;nM;22000.0;Protein binding affinity for human serum albumin was measured;Serum albumin;Homo sapiens;SINGLE PROTEIN;CHEMBL1136458
CHEMBL135463;FMS1-Gentamycin;CNC(C)[C@H]1CCC(N)[C@@H](O[C@@H]2C(N)C[C@@H](NC(=O)OCC3c4ccccc4-c4ccc(S(=O)(=O)O)cc43)C(O[C@H]3OC[C@](C)(O)C(NC)[C@@H]3O)[C@@H]2O)O1;Kd;20000.0;nM;20000.0;The compound was evaluated for pharmacokinetic parameters Serum albumin associating affinity;Serum albumin;Homo sapiens;SINGLE PROTEIN;CHEMBL1135785
CHEMBL1464;warfarin;CC(=O)CC(c1ccccc1)c1c(O)c2ccccc2oc1=O;Kd;2000.0;nM;2000.0;Binding affinity to human serum albumin at 20 degC by isothermal titration calorimetry analysis;Serum albumin;Homo sapiens;SINGLE PROTEIN;CHEMBL1772967
CHEMBL249674;6;N#Cc1ccc(NC(=O)c2ccc(S(=O)(=O)N3CCOCC3)cc2)c(C(=O)O)c1;Kd;2000.0;nM;2000.0;Binding to low affinity site of human serum albumin;Serum albumin;Homo sapiens;SINGLE PROTEIN;CHEMBL1139792
CHEMBL3601026;3;C=C(C)[C@@H]1CC[C@]2(C(=O)N[C@H](C)C(=O)[O-])CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CC[C@H](O)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]12.CCCCCCCCCCCC[N+](C)(C)Cc1ccccc1;Kd;19000.0;nM;19000.0;Binding affinity to human serum albumin with excitation at 285 nm after 30 mins by fluorescence spectrophotometric analysis;Serum albumin;Homo sapiens;SINGLE PROTEIN;CHEMBL3600335
CHEMBL3601026;3;C=C(C)[C@@H]1CC[C@]2(C(=O)N[C@H](C)C(=O)[O-])CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CC[C@H](O)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]12.CCCCCCCCCCCC[N+](C)(C)Cc1ccccc1;Kd;19000.0;nM;19000.0;Binding affinity to human serum albumin with excitation at 295 nm after 30 mins by fluorescence spectrophotometric analysis;Serum albumin;Homo sapiens;SINGLE PROTEIN;CHEMBL3600335
CHEMBL3601027;4;C=C(C)[C@@H]1CC[C@]2(C(=O)[O-])CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CC[C@H](O)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]12.CCCCCCCCCCCC[N+](C)(C)Cc1ccccc1;Kd;1900.0;nM;1900.0;Binding affinity to human serum albumin with excitation at 295 nm after 30 mins by fluorescence spectrophotometric analysis;Serum albumin;Homo sapiens;SINGLE PROTEIN;CHEMBL3600335
CHEMBL4574818;23a;CC(=O)c1cccc(N(CCO)c2nc(-c3sc(NC(=O)C(C)(C)C)nc3C)cs2)c1;Kd;18490.0;nM;18490.0;Binding affinity to human serum albumin assessed as dissociation constant incubated for 30 mins by spectrofluorimetry;Serum albumin;Homo sapiens;SINGLE PROTEIN;CHEMBL4321853
CHEMBL264831;FMS3-Gentamycin;CNC(C)[C@H]1CCC(NC(=O)OCC2c3ccccc3-c3ccc(S(=O)(=O)O)cc32)[C@@H](O[C@@H]2C(NC(=O)OCC3c4ccccc4-c4ccc(S(=O)(=O)O)cc43)C[C@@H](NC(=O)OCC3c4ccccc4-c4ccc(S(=O)(=O)O)cc43)C(O[C@H]3OC[C@](C)(O)C(NC)[C@@H]3O)[C@@H]2O)O1;Kd;17200.0;nM;17200.0;The compound was evaluated for albumin associating affinity along with 1.3 M of FMS;Serum albumin;Homo sapiens;SINGLE PROTEIN;CHEMBL1135785
CHEMBL3601027;4;C=C(C)[C@@H]1CC[C@]2(C(=O)[O-])CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CC[C@H](O)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]12.CCCCCCCCCCCC[N+](C)(C)Cc1ccccc1;Kd;1600.0;nM;1600.0;Binding affinity to human serum albumin with excitation at 285 nm after 30 mins by fluorescence spectrophotometric analysis;Serum albumin;Homo sapiens;SINGLE PROTEIN;CHEMBL3600335
CHEMBL419662;4;Cc1cc2c(C(C)C)c(O)c(O)c(C(=O)O)c2cc1-c1cc2c(C(=O)O)c(O)c(O)c(C(C)C)c2cc1C;Kd;1500.0;nM;1500.0;Compound was tested for binding activity to human serum albumin (HSA);Serum albumin;Homo sapiens;SINGLE PROTEIN;CHEMBL1128714
CHEMBL2326363;1a;O=C(O)Cc1ccccc1S(=O)(=O)c1ccc(-c2ccc(OCCF)cc2)cc1;Kd;140000.0;nM;140000.0;Binding affinity to human serum albumin by 19F NMR titration assay;Serum albumin;Homo sapiens;SINGLE PROTEIN;CHEMBL2321808
CHEMBL249674;6;N#Cc1ccc(NC(=O)c2ccc(S(=O)(=O)N3CCOCC3)cc2)c(C(=O)O)c1;Kd;14000.0;nM;14000.0;Binding to high affinity site of human serum albumin;Serum albumin;Homo sapiens;SINGLE PROTEIN;CHEMBL1139792
CHEMBL192571;73R;CN(C)CC[C@H](CSc1ccccc1)Nc1ccc(S(=O)(=O)NC(=O)c2ccc(N3CCC(C)(C)CC3)cc2)cc1[N+](=O)[O-];Kd;13600.0;nM;13600.0;Binding affinity for human serum albumin domain III;Serum albumin;Homo sapiens;SINGLE PROTEIN;CHEMBL1149415
CHEMBL473417;vismodegib, GDC-0449;CS(=O)(=O)c1ccc(C(=O)Nc2ccc(Cl)c(-c3ccccn3)c2)c(Cl)c1;Kd;130000.0;nM;130000.0;Binding affinity to high-affinity binding site of human serum albumin at 20 degC by surface plasmon resonance assay;Serum albumin;Homo sapiens;SINGLE PROTEIN;CHEMBL1772967
CHEMBL269277;1, Betulinic acid;C=C(C)[C@@H]1CC[C@]2(C(=O)O)CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CC[C@H](O)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]12;Kd;1300.0;nM;1300.0;Binding affinity to human serum albumin with excitation at 295 nm after 30 mins by fluorescence spectrophotometric analysis;Serum albumin;Homo sapiens;SINGLE PROTEIN;CHEMBL3600335
CHEMBL898;diflunisol;O=C(O)c1cc(-c2ccc(F)cc2F)ccc1O;Kd;1230.27;nM;1230.27;Binding affinity to human serum albumin by PAMPA method;Serum albumin;Homo sapiens;SINGLE PROTEIN;CHEMBL1144698
CHEMBL473417;vismodegib, GDC-0449;CS(=O)(=O)c1ccc(C(=O)Nc2ccc(Cl)c(-c3ccccn3)c2)c(Cl)c1;Kd;120000.0;nM;120000.0;Binding affinity to human serum albumin at 37 degC by surface plasmon resonance assay;Serum albumin;Homo sapiens;SINGLE PROTEIN;CHEMBL1772967
CHEMBL1447;Lincomycin;CCC[C@@H]1C[C@@H](C(=O)N[C@H]([C@@H](C)O)[C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)N(C)C1;Kd;12000.0;nM;12000.0;Binding affinity to first site on human serum albumin by SPR;Serum albumin;Homo sapiens;SINGLE PROTEIN;CHEMBL1649135
CHEMBL1730;CTX, cefotaxime;CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(C)=O)CS[C@H]12)c1csc(N)n1;Kd;12000.0;nM;12000.0;Binding affinity to first site on human serum albumin by SPR;Serum albumin;Homo sapiens;SINGLE PROTEIN;CHEMBL1649135
CHEMBL36506;Novobiocin;CO[C@@H]1[C@@H](OC(N)=O)[C@@H](O)[C@H](Oc2ccc3c(O)c(NC(=O)c4ccc(O)c(CC=C(C)C)c4)c(=O)oc3c2C)OC1(C)C;Kd;12000.0;nM;12000.0;Binding affinity to first site on human serum albumin by SPR;Serum albumin;Homo sapiens;SINGLE PROTEIN;CHEMBL1649135
CHEMBL532;Erythromycin;CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O;Kd;12000.0;nM;12000.0;Binding affinity to first site on human serum albumin by SPR;Serum albumin;Homo sapiens;SINGLE PROTEIN;CHEMBL1649135
CHEMBL374478;Rifampin;CO[C@H]1/C=C/O[C@@]2(C)Oc3c(C)c(O)c4c(O)c(c(/C=N/N5CCN(C)CC5)c(O)c4c3C2=O)NC(=O)/C(C)=C\C=C\[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C;Kd;12000.0;nM;12000.0;Binding affinity to first site on human serum albumin by SPR;Serum albumin;Homo sapiens;SINGLE PROTEIN;CHEMBL1649135
CHEMBL4;Ofloxacin;CC1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23;Kd;12000.0;nM;12000.0;Binding affinity to first site on human serum albumin by SPR;Serum albumin;Homo sapiens;SINGLE PROTEIN;CHEMBL1649135
CHEMBL262777;Vancomycin;CN[C@H](CC(C)C)C(=O)N[C@H]1C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]2C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c4cc(O)cc(O)c4-c4cc3ccc4O)[C@H](O)c3ccc(c(Cl)c3)Oc3cc2cc(c3O[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O[C@H]2C[C@](C)(N)[C@H](O)[C@H](C)O2)Oc2ccc(cc2Cl)[C@H]1O;Kd;12000.0;nM;12000.0;Binding affinity to first site on human serum albumin by SPR;Serum albumin;Homo sapiens;SINGLE PROTEIN;CHEMBL1649135
CHEMBL374975;Fusidic acid;CC(=O)O[C@H]1C[C@@]2(C)[C@@H](C[C@@H](O)[C@H]3[C@@]4(C)CC[C@@H](O)[C@@H](C)[C@@H]4CC[C@@]32C)/C1=C(\CCC=C(C)C)C(=O)O;Kd;12000.0;nM;12000.0;Binding affinity to first site on human serum albumin by SPR;Serum albumin;Homo sapiens;SINGLE PROTEIN;CHEMBL1649135
CHEMBL1434;Minocycline;CN(C)c1ccc(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O;Kd;12000.0;nM;12000.0;Binding affinity to first site on human serum albumin by SPR;Serum albumin;Homo sapiens;SINGLE PROTEIN;CHEMBL1649135
CHEMBL1464;warfarin;CC(=O)CC(c1ccccc1)c1c(O)c2ccccc2oc1=O;Kd;12000.0;nM;12000.0;Binding affinity to human serum albumin at 37 degC by surface plasmon resonance assay;Serum albumin;Homo sapiens;SINGLE PROTEIN;CHEMBL1772967
CHEMBL311591;3;Cc1cc2c(C(C)C)c(O)c(O)c(C=O)c2cc1-c1cc2c(C=O)c(O)c(O)c(C(C)C)c2cc1C;Kd;1200.0;nM;1200.0;Compound was tested for binding activity to human serum albumin (HSA);Serum albumin;Homo sapiens;SINGLE PROTEIN;CHEMBL1128714
CHEMBL260775;"5; Corr-4a";COc1ccc(Cl)cc1Nc1nc(-c2sc(NC(=O)c3ccccc3)nc2C)cs1;Kd;11680.0;nM;11680.0;Binding affinity to human serum albumin assessed as dissociation constant incubated for 30 mins by spectrofluorimetry;Serum albumin;Homo sapiens;SINGLE PROTEIN;CHEMBL4321853
CHEMBL596596;3b;CN(C)C1=NN(c2ccc(Cl)cc2)CN(c2ccccc2Cl)C1=O;Kd;10210.0;nM;10210.0;Binding affinity to HSA after 30 mins assessed as quenching of intrinsic HSA fluorescence emission by spectrofluorimetric assay;Serum albumin;Homo sapiens;SINGLE PROTEIN;CHEMBL1157585
CHEMBL4464312;19;COc1ccc2oc(-c3csc4ccccc34)c(O)c(=O)c2c1;Kd;10000.0;nM;10000.0;Binding affinity to human serum albumin by fluorescence based assay;Serum albumin;Homo sapiens;SINGLE PROTEIN;CHEMBL4311972
CHEMBL2326365;1c;O=C(O)Cc1ccccc1S(=O)(=O)c1ccc(-c2ccc(NC(=O)CF)cc2)cc1;Kd;10000.0;nM;10000.0;Binding affinity to human serum albumin by 19F NMR titration assay;Serum albumin;Homo sapiens;SINGLE PROTEIN;CHEMBL2321808
CHEMBL1000;Cetirizine;O=C(O)COCCN1CCN(C(c2ccccc2)c2ccc(Cl)cc2)CC1;Ka;5.42;M/M;184501845;compound was evaluated for association constant (Ka) of isolated serum protein HSA with FFA;Serum albumin;Homo sapiens;SINGLE PROTEIN;CHEMBL1131523
CHEMBL85139;1a;O=c1c2ccccc2nc2n1CCc1c-2[nH]c2ccccc12;Ka;1000.000;M;1000000;Binding affinity to human serum albumin by affinity chromatographic method;Serum albumin;Homo sapiens;SINGLE PROTEIN;CHEMBL4043261
CHEMBL261104;7-AZT-Pro;Cc1cn(C[C@H]2C[C@H](N=[N+]=[N-])[C@@H](COC(=O)C(=O)N3CCC[C@H]3C(=O)O)O2)c(=O)[nH]c1=O;Ka;944.6;L/mol;1058649.164;Binding affinity to defatted human serum albumin;Serum albumin;Homo sapiens;SINGLE PROTEIN;CHEMBL1143998
CHEMBL406933;5-AZT-Val;Cc1cn(C[C@H]2C[C@H](N=[N+]=[N-])[C@@H](COC(=O)C(=O)N[C@H](C(=O)O)C(C)C)O2)c(=O)[nH]c1=O;Ka;944.6;L/mol;1058649.164;Binding affinity to fatty acid complexed human serum albumin;Serum albumin;Homo sapiens;SINGLE PROTEIN;CHEMBL1143998
CHEMBL406638;9-AZT-Tyr;Cc1cn(C[C@H]2C[C@H](N=[N+]=[N-])[C@@H](COC(=O)C(=O)N[C@@H](Cc3ccc(O)cc3)C(=O)O)O2)c(=O)[nH]c1=O;Ka;890.90;L/mol;1122460.433;Binding affinity to fatty acid complexed human serum albumin;Serum albumin;Homo sapiens;SINGLE PROTEIN;CHEMBL1143998
CHEMBL260711;10-AZT-Ac;Cc1cn(C[C@H]2C[C@H](N=[N+]=[N-])[C@@H](COC(=O)C(=O)O)O2)c(=O)[nH]c1=O;Ka;811.7;L/mol;1231982.259;Binding affinity to fatty acid complexed human serum albumin;Serum albumin;Homo sapiens;SINGLE PROTEIN;CHEMBL1143998
CHEMBL406638;9-AZT-Tyr;Cc1cn(C[C@H]2C[C@H](N=[N+]=[N-])[C@@H](COC(=O)C(=O)N[C@@H](Cc3ccc(O)cc3)C(=O)O)O2)c(=O)[nH]c1=O;Ka;811.7;L/mol;1231982.259;Binding affinity to defatted human serum albumin in presence of salicylic acid;Serum albumin;Homo sapiens;SINGLE PROTEIN;CHEMBL1143998
CHEMBL261104;7-AZT-Pro;Cc1cn(C[C@H]2C[C@H](N=[N+]=[N-])[C@@H](COC(=O)C(=O)N3CCC[C@H]3C(=O)O)O2)c(=O)[nH]c1=O;Ka;811.7;L/mol;1231982.259;Binding affinity to defatted human serum albumin in presence of salicylic acid;Serum albumin;Homo sapiens;SINGLE PROTEIN;CHEMBL1143998
CHEMBL409705;6-AZT-Pha;Cc1cn(C[C@H]2C[C@H](N=[N+]=[N-])[C@@H](COC(=O)C(=O)N[C@@H](Cc3ccccc3)C(=O)O)O2)c(=O)[nH]c1=O;Ka;716.7;L/mol;1395283.94;Binding affinity to defatted human serum albumin in presence of salicylic acid;Serum albumin;Homo sapiens;SINGLE PROTEIN;CHEMBL1143998
CHEMBL412092;3-AZT-Leu;Cc1cn(C[C@H]2C[C@H](N=[N+]=[N-])[C@@H](COC(=O)C(=O)N[C@@H](CC(C)C)C(=O)O)O2)c(=O)[nH]c1=O;Ka;683.2;L/mol;1463700.234;Binding affinity to fatty acid complexed human serum albumin;Serum albumin;Homo sapiens;SINGLE PROTEIN;CHEMBL1143998
CHEMBL260711;10-AZT-Ac;Cc1cn(C[C@H]2C[C@H](N=[N+]=[N-])[C@@H](COC(=O)C(=O)O)O2)c(=O)[nH]c1=O;Ka;6201.3;L/mol;161256.5107;Binding affinity to defatted human serum albumin;Serum albumin;Homo sapiens;SINGLE PROTEIN;CHEMBL1143998
CHEMBL260711;10-AZT-Ac;Cc1cn(C[C@H]2C[C@H](N=[N+]=[N-])[C@@H](COC(=O)C(=O)O)O2)c(=O)[nH]c1=O;Ka;604.5;L/mol;1654259.719;Binding affinity to defatted human serum albumin in presence of salicylic acid;Serum albumin;Homo sapiens;SINGLE PROTEIN;CHEMBL1143998
CHEMBL411891;4-AZT-iLeu;CC[C@H](C)[C@H](NC(=O)C(=O)OC[C@H]1O[C@@H](Cn2cc(C)c(=O)[nH]c2=O)C[C@@H]1N=[N+]=[N-])C(=O)O;Ka;575.2;L/mol;1738525.73;Binding affinity to fatty acid complexed human serum albumin;Serum albumin;Homo sapiens;SINGLE PROTEIN;CHEMBL1143998
CHEMBL412092;3-AZT-Leu;Cc1cn(C[C@H]2C[C@H](N=[N+]=[N-])[C@@H](COC(=O)C(=O)N[C@@H](CC(C)C)C(=O)O)O2)c(=O)[nH]c1=O;Ka;449.0;L/mol;2227171.492;Binding affinity to defatted human serum albumin in presence of salicylic acid;Serum albumin;Homo sapiens;SINGLE PROTEIN;CHEMBL1143998
CHEMBL409705;6-AZT-Pha;Cc1cn(C[C@H]2C[C@H](N=[N+]=[N-])[C@@H](COC(=O)C(=O)N[C@@H](Cc3ccccc3)C(=O)O)O2)c(=O)[nH]c1=O;Ka;436.6;L/mol;2290426.019;Binding affinity to fatty acid complexed human serum albumin;Serum albumin;Homo sapiens;SINGLE PROTEIN;CHEMBL1143998
CHEMBL411891;4-AZT-iLeu;CC[C@H](C)[C@H](NC(=O)C(=O)OC[C@H]1O[C@@H](Cn2cc(C)c(=O)[nH]c2=O)C[C@@H]1N=[N+]=[N-])C(=O)O;Ka;397.2;L/mol;2517623.364;Binding affinity to defatted human serum albumin in presence of salicylic acid;Serum albumin;Homo sapiens;SINGLE PROTEIN;CHEMBL1143998
CHEMBL411891;4-AZT-iLeu;CC[C@H](C)[C@H](NC(=O)C(=O)OC[C@H]1O[C@@H](Cn2cc(C)c(=O)[nH]c2=O)C[C@@H]1N=[N+]=[N-])C(=O)O;Ka;3765.4;L/mol;265576.0344;Binding affinity to defatted human serum albumin;Serum albumin;Homo sapiens;SINGLE PROTEIN;CHEMBL1143998
CHEMBL261329;2-AZT-Iso;Cc1cn(C[C@H]2C[C@H](N=[N+]=[N-])[C@@H](COC(=O)c3ccncc3)O2)c(=O)[nH]c1=O;Ka;3277.3;L/mol;305129.2222;Binding affinity to fatty acid complexed human serum albumin;Serum albumin;Homo sapiens;SINGLE PROTEIN;CHEMBL1143998
CHEMBL412092;3-AZT-Leu;Cc1cn(C[C@H]2C[C@H](N=[N+]=[N-])[C@@H](COC(=O)C(=O)N[C@@H](CC(C)C)C(=O)O)O2)c(=O)[nH]c1=O;Ka;2457.0;L/mol;407000.407;Binding affinity to defatted human serum albumin;Serum albumin;Homo sapiens;SINGLE PROTEIN;CHEMBL1143998
CHEMBL409624;8-AZT-Trp;Cc1cn(C[C@H]2C[C@H](N=[N+]=[N-])[C@@H](COC(=O)C(=O)N[C@@H](Cc3c[nH]c4ccccc34)C(=O)O)O2)c(=O)[nH]c1=O;Ka;2172.1;L/mol;460383.9602;Binding affinity to fatty acid complexed human serum albumin;Serum albumin;Homo sapiens;SINGLE PROTEIN;CHEMBL1143998
CHEMBL409624;8-AZT-Trp;Cc1cn(C[C@H]2C[C@H](N=[N+]=[N-])[C@@H](COC(=O)C(=O)N[C@@H](Cc3c[nH]c4ccccc34)C(=O)O)O2)c(=O)[nH]c1=O;Ka;1803.2;L/mol;554569.6539;Binding affinity to defatted human serum albumin;Serum albumin;Homo sapiens;SINGLE PROTEIN;CHEMBL1143998
CHEMBL261858;1-AZT;Cc1cn(C[C@H]2C[C@H](N=[N+]=[N-])[C@@H](CO)O2)c(=O)[nH]c1=O;Ka;1790.7;L/mol;558440.8332;Binding affinity to fatty acid complexed human serum albumin;Serum albumin;Homo sapiens;SINGLE PROTEIN;CHEMBL1143998
CHEMBL261329;2-AZT-Iso;Cc1cn(C[C@H]2C[C@H](N=[N+]=[N-])[C@@H](COC(=O)c3ccncc3)O2)c(=O)[nH]c1=O;Ka;1709.8;L/mol;584863.7268;Binding affinity to defatted human serum albumin;Serum albumin;Homo sapiens;SINGLE PROTEIN;CHEMBL1143998
CHEMBL406933;5-AZT-Val;Cc1cn(C[C@H]2C[C@H](N=[N+]=[N-])[C@@H](COC(=O)C(=O)N[C@H](C(=O)O)C(C)C)O2)c(=O)[nH]c1=O;Ka;1535.0;L/mol;651465.798;Binding affinity to defatted human serum albumin;Serum albumin;Homo sapiens;SINGLE PROTEIN;CHEMBL1143998
CHEMBL409624;8-AZT-Trp;Cc1cn(C[C@H]2C[C@H](N=[N+]=[N-])[C@@H](COC(=O)C(=O)N[C@@H](Cc3c[nH]c4ccccc34)C(=O)O)O2)c(=O)[nH]c1=O;Ka;1519.8;L/mol;657981.3133;Binding affinity to defatted human serum albumin in presence of salicylic acid;Serum albumin;Homo sapiens;SINGLE PROTEIN;CHEMBL1143998
CHEMBL261104;7-AZT-Pro;Cc1cn(C[C@H]2C[C@H](N=[N+]=[N-])[C@@H](COC(=O)C(=O)N3CCC[C@H]3C(=O)O)O2)c(=O)[nH]c1=O;Ka;1341.9;L/mol;745212.0128;Binding affinity to fatty acid complexed human serum albumin;Serum albumin;Homo sapiens;SINGLE PROTEIN;CHEMBL1143998
CHEMBL406933;5-AZT-Val;Cc1cn(C[C@H]2C[C@H](N=[N+]=[N-])[C@@H](COC(=O)C(=O)N[C@H](C(=O)O)C(C)C)O2)c(=O)[nH]c1=O;Ka;1312.6;L/mol;761846.7164;Binding affinity to defatted human serum albumin in presence of salicylic acid;Serum albumin;Homo sapiens;SINGLE PROTEIN;CHEMBL1143998
CHEMBL261858;1-AZT;Cc1cn(C[C@H]2C[C@H](N=[N+]=[N-])[C@@H](CO)O2)c(=O)[nH]c1=O;Ka;129.5;L/mol;7722007.722;Binding affinity to defatted human serum albumin in presence of salicylic acid;Serum albumin;Homo sapiens;SINGLE PROTEIN;CHEMBL1143998
CHEMBL406638;9-AZT-Tyr;Cc1cn(C[C@H]2C[C@H](N=[N+]=[N-])[C@@H](COC(=O)C(=O)N[C@@H](Cc3ccc(O)cc3)C(=O)O)O2)c(=O)[nH]c1=O;Ka;1224.4;L/mol;816726.5599;Binding affinity to defatted human serum albumin;Serum albumin;Homo sapiens;SINGLE PROTEIN;CHEMBL1143998
CHEMBL409705;6-AZT-Pha;Cc1cn(C[C@H]2C[C@H](N=[N+]=[N-])[C@@H](COC(=O)C(=O)N[C@@H](Cc3ccccc3)C(=O)O)O2)c(=O)[nH]c1=O;Ka;1174.4;L/mol;851498.6376;Binding affinity to defatted human serum albumin;Serum albumin;Homo sapiens;SINGLE PROTEIN;CHEMBL1143998
CHEMBL261858;1-AZT;Cc1cn(C[C@H]2C[C@H](N=[N+]=[N-])[C@@H](CO)O2)c(=O)[nH]c1=O;Ka;1044.9;L/mol;957029.3808;Binding affinity to defatted human serum albumin;Serum albumin;Homo sapiens;SINGLE PROTEIN;CHEMBL1143998
CHEMBL504510;5;O=C(O)CCCCCOc1ccc(/C=C/c2cc(O)cc(O)c2)cc1;Ka;3.12;10'-6/M;320.51;Binding affinity to human serum albumin assessed as increase in drug-induced fluorescence at 4 uM by fluorescence enhancing measurement;Serum albumin;Homo sapiens;SINGLE PROTEIN;CHEMBL1150416
CHEMBL1450;ATO;O=C1C(O)=C([C@H]2CC[C@H](c3ccc(Cl)cc3)CC2)C(=O)c2ccccc21;Ka;2.0;10'6/M;500.00;Binding affinity to human serum albumin by CD spectroscopy;Serum albumin;Homo sapiens;SINGLE PROTEIN;CHEMBL3580619
CHEMBL4164587;12;O=C(O)/C(O)=C/C(=O)c1cc(C2CCCCC2)ccc1C1CCCCC1;Ka;1.06;10'6/M;943.40;Binding affinity to human serum albumin at 293K by Stern-Volmer plot method;Serum albumin;Homo sapiens;SINGLE PROTEIN;CHEMBL4138171
CHEMBL4164587;12;O=C(O)/C(O)=C/C(=O)c1cc(C2CCCCC2)ccc1C1CCCCC1;Ka;1.02;10'6/M;980.39;Binding affinity to human serum albumin at 303K by Stern-Volmer plot method;Serum albumin;Homo sapiens;SINGLE PROTEIN;CHEMBL4138171
CHEMBL4164587;12;O=C(O)/C(O)=C/C(=O)c1cc(C2CCCCC2)ccc1C1CCCCC1;Ka;0.95;10'6/M;1052.63;Binding affinity to human serum albumin at 310K by Stern-Volmer plot method;Serum albumin;Homo sapiens;SINGLE PROTEIN;CHEMBL4138171
CHEMBL139;Dic;O=C(O)Cc1ccccc1Nc1c(Cl)cccc1Cl;Ka;0.1;10'6/M;10000.00;Binding affinity to human serum albumin assessed as association constant to higher affinity site by HPLC method;Serum albumin;Homo sapiens;SINGLE PROTEIN;CHEMBL3751827
CHEMBL269277;1, Betulinic acid;C=C(C)[C@@H]1CC[C@]2(C(=O)O)CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CC[C@H](O)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]12;Ka;1685.00;10'6/M;0.59;Binding affinity to human serum albumin with excitation at 285 nm assessed as association constant by fluorescence emission spectroscopic analysis;Serum albumin;Homo sapiens;SINGLE PROTEIN;CHEMBL3600335
CHEMBL3824037;12b;CCn1cc(-c2csc(N)n2)c(=O)c2cc(N3CCCC3)c(Cl)cc21;Ka;1.47;10'5L/mol;6802.72;Binding affinity to human serum albumin at pH 7.4 at 288 K by Stern-Volmer plot analysis;Serum albumin;Homo sapiens;SINGLE PROTEIN;CHEMBL3822423
CHEMBL3824037;12b;CCn1cc(-c2csc(N)n2)c(=O)c2cc(N3CCCC3)c(Cl)cc21;Ka;1.39;10'5L/mol;7194.24;Binding affinity to human serum albumin at pH 7.4 at 303 K by Stern-Volmer plot analysis;Serum albumin;Homo sapiens;SINGLE PROTEIN;CHEMBL3822423
CHEMBL3824037;12b;CCn1cc(-c2csc(N)n2)c(=O)c2cc(N3CCCC3)c(Cl)cc21;Ka;1.37;10'5L/mol;7299.27;Binding affinity to human serum albumin at pH 7.4 at 310 K by Stern-Volmer plot analysis;Serum albumin;Homo sapiens;SINGLE PROTEIN;CHEMBL3822423
CHEMBL51483;SID50104971;Cc1cc2c(C(C)C)c(O)c(O)c(C=O)c2c(O)c1-c1c(C)cc2c(C(C)C)c(O)c(O)c(C=O)c2c1O;Ka;2391.00;10'5L/mol;4.18;Binding affinity to human serum albumin by fluorescence quenching assay;Serum albumin;Homo sapiens;SINGLE PROTEIN;CHEMBL1949531
CHEMBL1949749;16;Cc1cc2c(c(O)c1-c1c(C)cc3c(c1O)/C(=C/N[C@H](C(=O)[O-])C(C)C)C(=O)C(O)=C3C(C)C)/C(=C/N[C@H](C(=O)[O-])C(C)C)C(=O)C(O)=C2C(C)C.[Na+].[Na+];Ka;2114.00;10'5L/mol;4.73;Binding affinity to human serum albumin by fluorescence quenching assay;Serum albumin;Homo sapiens;SINGLE PROTEIN;CHEMBL1949531
CHEMBL1949748;15;Cc1cc2c(c(O)c1-c1c(C)cc3c(c1O)/C(=C/NC(C)(C)C(=O)[O-])C(=O)C(O)=C3C(C)C)/C(=C/NC(C)(C)C(=O)[O-])C(=O)C(O)=C2C(C)C.[Na+].[Na+];Ka;1913.00;10'5L/mol;5.23;Binding affinity to human serum albumin by fluorescence quenching assay;Serum albumin;Homo sapiens;SINGLE PROTEIN;CHEMBL1949531
CHEMBL1215008;11;Cc1cc2c(C(C)C)c(O)c(O)c(/C=N/[C@@H](Cc3ccccc3)C(=O)[O-])c2c(O)c1-c1c(C)cc2c(C(C)C)c(O)c(O)c(/C=N/[C@@H](Cc3ccccc3)C(=O)[O-])c2c1O.[Na+].[Na+];Ka;1284.00;10'5L/mol;7.79;Binding affinity to human serum albumin by fluorescence quenching assay;Serum albumin;Homo sapiens;SINGLE PROTEIN;CHEMBL1949531
CHEMBL1949747;14;Cc1cc2c(c(O)c1-c1c(C)cc3c(c1O)/C(=C/N[C@@H](C)C(=O)[O-])C(=O)C(O)=C3C(C)C)/C(=C/N[C@@H](C)C(=O)[O-])C(=O)C(O)=C2C(C)C.[Na+].[Na+];Ka;1039.00;10'5L/mol;9.62;Binding affinity to human serum albumin by fluorescence quenching assay;Serum albumin;Homo sapiens;SINGLE PROTEIN;CHEMBL1949531
CHEMBL504510;5;O=C(O)CCCCCOc1ccc(/C=C/c2cc(O)cc(O)c2)cc1;Ka;67.0;10'5/M;149.25;Binding affinity to human serum albumin by fluorescence quenching measurement;Serum albumin;Homo sapiens;SINGLE PROTEIN;CHEMBL1150416
CHEMBL504510;5;O=C(O)CCCCCOc1ccc(/C=C/c2cc(O)cc(O)c2)cc1;Ka;31.2;10'5/M;320.51;Binding affinity to human serum albumin at 4 uM by fluorescence enhancing measurement;Serum albumin;Homo sapiens;SINGLE PROTEIN;CHEMBL1150416
CHEMBL483118;3;COC(=O)CCCCCOc1ccc(/C=C/c2cc(O)cc(O)c2)cc1;Ka;3.05;10'5/M;3278.69;Binding affinity to human serum albumin by fluorescence quenching measurement;Serum albumin;Homo sapiens;SINGLE PROTEIN;CHEMBL1150416
CHEMBL504510;5;O=C(O)CCCCCOc1ccc(/C=C/c2cc(O)cc(O)c2)cc1;Ka;26.2;10'5/M;381.68;Binding affinity to human serum albumin at 4 uM by UV-vis measurement;Serum albumin;Homo sapiens;SINGLE PROTEIN;CHEMBL1150416
CHEMBL455060;4;O=C(O)COc1ccc(/C=C/c2cc(O)cc(O)c2)cc1;Ka;2.95;10'5/M;3389.83;Binding affinity to human serum albumin by fluorescence quenching measurement;Serum albumin;Homo sapiens;SINGLE PROTEIN;CHEMBL1150416
CHEMBL165;1;Oc1ccc(/C=C/c2cc(O)cc(O)c2)cc1;Ka;1.64;10'5/M;6097.56;Binding affinity to human serum albumin by fluorescence quenching measurement;Serum albumin;Homo sapiens;SINGLE PROTEIN;CHEMBL1150416
CHEMBL488354;2;CCOC(=O)COc1ccc(/C=C/c2cc(O)cc(O)c2)cc1;Ka;1.14;10'5/M;8771.93;Binding affinity to human serum albumin by fluorescence quenching measurement;Serum albumin;Homo sapiens;SINGLE PROTEIN;CHEMBL1150416
CHEMBL139;Dic;O=C(O)Cc1ccccc1Nc1c(Cl)cccc1Cl;Ka;0.076;10'5/M;131578.95;Binding affinity to human serum albumin by equilibrium dialysis;Serum albumin;Homo sapiens;SINGLE PROTEIN;CHEMBL3751827
CHEMBL139;Dic;O=C(O)Cc1ccccc1Nc1c(Cl)cccc1Cl;Ka;0.03;10'5/M;333333.33;Binding affinity to human serum albumin assessed as association constant to lower affinity site by HPLC method;Serum albumin;Homo sapiens;SINGLE PROTEIN;CHEMBL3751827
CHEMBL106;FCZ;OC(Cn1cncn1)(Cn1cncn1)c1ccc(F)cc1F;Ka;7.18;10'-4L/mol;13927.58;Binding affinity to human serum albumin by spectroscopy in presence of Zn2+;Serum albumin;Homo sapiens;SINGLE PROTEIN;CHEMBL3351322
CHEMBL106;FCZ;OC(Cn1cncn1)(Cn1cncn1)c1ccc(F)cc1F;Ka;7.0;10'-4L/mol;14285.71;Binding affinity to human serum albumin by spectroscopy in presence of Mg2+;Serum albumin;Homo sapiens;SINGLE PROTEIN;CHEMBL3351322
CHEMBL4279693;7d;Cc1ccc(-c2cc(-c3nc4ccccc4[nH]3)nc(N)n2)cc1;Ka;6.96;10'-4L/mol;14367.82;Binding affinity to HSA assessed as modified Stern-Volmer quenching constant at pH 7.4 at 298 K by fluorescence spectroscopic analysis;Serum albumin;Homo sapiens;SINGLE PROTEIN;CHEMBL4251572
CHEMBL106;FCZ;OC(Cn1cncn1)(Cn1cncn1)c1ccc(F)cc1F;Ka;6.47;10'-4L/mol;15455.95;Binding affinity to human serum albumin by spectroscopy;Serum albumin;Homo sapiens;SINGLE PROTEIN;CHEMBL3351322
CHEMBL106;Fluconazole;OC(Cn1cncn1)(Cn1cncn1)c1ccc(F)cc1F;Ka;6.47;10'-4L/mol;15455.95;Binding affinity to human serum albumin at 298 K by modified Stern-Volmer method;Serum albumin;Homo sapiens;SINGLE PROTEIN;CHEMBL3351322
CHEMBL106;F;OC(Cn1cncn1)(Cn1cncn1)c1ccc(F)cc1F;Ka;6.22;10'-4L/mol;16077.17;Binding affinity to human serum albumin by spectroscopy in presence of Cu2+;Serum albumin;Homo sapiens;SINGLE PROTEIN;CHEMBL3351322
CHEMBL106;Fluconazole;OC(Cn1cncn1)(Cn1cncn1)c1ccc(F)cc1F;Ka;6.22;10'-4L/mol;16077.17;Binding affinity to human serum albumin at 302 K by modified Stern-Volmer method;Serum albumin;Homo sapiens;SINGLE PROTEIN;CHEMBL3351322
CHEMBL106;FCZ;OC(Cn1cncn1)(Cn1cncn1)c1ccc(F)cc1F;Ka;6.19;10'-4L/mol;16155.09;Binding affinity to human serum albumin by spectroscopy in presence of Ba2+;Serum albumin;Homo sapiens;SINGLE PROTEIN;CHEMBL3351322
CHEMBL106;Fluconazole;OC(Cn1cncn1)(Cn1cncn1)c1ccc(F)cc1F;Ka;6.12;10'-4L/mol;16339.87;Binding affinity to human serum albumin by spectroscopy in presence of Co2+;Serum albumin;Homo sapiens;SINGLE PROTEIN;CHEMBL3351322
CHEMBL4279693;7d;Cc1ccc(-c2cc(-c3nc4ccccc4[nH]3)nc(N)n2)cc1;Ka;6.04;10'-4L/mol;16556.29;Binding affinity to HSA assessed as modified Stern-Volmer quenching constant at pH 7.4 at 303 K by fluorescence spectroscopic analysis;Serum albumin;Homo sapiens;SINGLE PROTEIN;CHEMBL4251572
CHEMBL1977368;SID505515;OC(Cn1cncn1)(Cn1cncn1)c1ccc(Cl)cc1Cl;Ka;6.03;10'-4L/mol;16583.75;Binding affinity to human serum albumin at 298 K by modified Stern-Volmer method;Serum albumin;Homo sapiens;SINGLE PROTEIN;CHEMBL3351322
CHEMBL106;FCZ;OC(Cn1cncn1)(Cn1cncn1)c1ccc(F)cc1F;Ka;5.86;10'-4L/mol;17064.85;Binding affinity to human serum albumin by spectroscopy in presence of La3+;Serum albumin;Homo sapiens;SINGLE PROTEIN;CHEMBL3351322
CHEMBL1977368;DTP;OC(Cn1cncn1)(Cn1cncn1)c1ccc(Cl)cc1Cl;Ka;5.76;10'-4L/mol;17361.11;Binding affinity to human serum albumin at 302 K by modified Stern-Volmer method;Serum albumin;Homo sapiens;SINGLE PROTEIN;CHEMBL3351322
CHEMBL106;Fluconazole;OC(Cn1cncn1)(Cn1cncn1)c1ccc(F)cc1F;Ka;5.65;10'-4L/mol;17699.12;Binding affinity to human serum albumin at 310 K by modified Stern-Volmer method;Serum albumin;Homo sapiens;SINGLE PROTEIN;CHEMBL3351322
CHEMBL106;FLU;OC(Cn1cncn1)(Cn1cncn1)c1ccc(F)cc1F;Ka;5.62;10'-4L/mol;17793.59;Binding affinity to human serum albumin by spectroscopy in presence of Mn2+;Serum albumin;Homo sapiens;SINGLE PROTEIN;CHEMBL3351322
CHEMBL106;Fluconazole;OC(Cn1cncn1)(Cn1cncn1)c1ccc(F)cc1F;Ka;5.6;10'-4L/mol;17857.14;Binding affinity to human serum albumin by spectroscopy in presence of Cr3+;Serum albumin;Homo sapiens;SINGLE PROTEIN;CHEMBL3351322
CHEMBL106;Fluconazole;OC(Cn1cncn1)(Cn1cncn1)c1ccc(F)cc1F;Ka;5.55;10'-4L/mol;18018.02;Binding affinity to human serum albumin by spectroscopy in presence of Ni2+;Serum albumin;Homo sapiens;SINGLE PROTEIN;CHEMBL3351322
CHEMBL2401877;5g;COc1ccc2cc3[n+](cc2c1OCCN(CCn1cncc1[N+](=O)[O-])Cc1ccc(F)cc1F)CCc1cc2c(cc1-3)OCO2.[Cl-];Ka;5.49;10'-4L/mol;18214.94;Binding affinity to human serum albumin assessed as effective quenching constant at pH 7.4 at 286K by modified Stern-Volmer method;Serum albumin;Homo sapiens;SINGLE PROTEIN;CHEMBL2401717
CHEMBL4170702;5c;CC(=O)Nc1ccc(S(=O)(=O)Cc2nc3ccccc3n2Cc2ccc(F)cc2)cc1;Ka;5.43;10'-4L/mol;18416.21;Binding affinity to human serum albumin at 273 K by modified Stern-Volmer method;Serum albumin;Homo sapiens;SINGLE PROTEIN;CHEMBL4138085
CHEMBL1977368;SID505515;OC(Cn1cncn1)(Cn1cncn1)c1ccc(Cl)cc1Cl;Ka;5.11;10'-4L/mol;19569.47;Binding affinity to human serum albumin at 310 K by modified Stern-Volmer method;Serum albumin;Homo sapiens;SINGLE PROTEIN;CHEMBL3351322
CHEMBL3099077;9a;O=C(/C(=C/c1ccccc1)n1cncn1)c1ccc(F)cc1N1CCCCC1;Ka;4.82;10'-4L/mol;20746.89;Binding affinity to human serum albumin at 298 K by molecular spectroscopic analysis in presence of K+;Serum albumin;Homo sapiens;SINGLE PROTEIN;CHEMBL3098086
CHEMBL106;Fluconazole;OC(Cn1cncn1)(Cn1cncn1)c1ccc(F)cc1F;Ka;4.8;10'-4L/mol;20833.33;Binding affinity to human serum albumin by spectroscopy in presence of Fe3+;Serum albumin;Homo sapiens;SINGLE PROTEIN;CHEMBL3351322
CHEMBL3099077;9a;O=C(/C(=C/c1ccccc1)n1cncn1)c1ccc(F)cc1N1CCCCC1;Ka;4.54;10'-4L/mol;22026.43;Binding affinity to human serum albumin at pH 7.4 at 286 K by modified Stern-Volmer method;Serum albumin;Homo sapiens;SINGLE PROTEIN;CHEMBL3098086
CHEMBL3099077;9a;O=C(/C(=C/c1ccccc1)n1cncn1)c1ccc(F)cc1N1CCCCC1;Ka;4.19;10'-4L/mol;23866.35;Binding affinity to human serum albumin at 298 K by molecular spectroscopic analysis in presence of Fe3+;Serum albumin;Homo sapiens;SINGLE PROTEIN;CHEMBL3098086
CHEMBL2312328;7a;COc1ccc2cc3[n+](cc2c1OCCN(CCn1cncn1)Cc1ccc(F)cc1F)CCc1cc2c(cc1-3)OCO2.[Cl-];Ka;4.03;10'-4L/mol;24813.90;Binding affinity to human serum albumin at pH 7.4 at 294 K by modified Stern-Volmer plot analysis;Serum albumin;Homo sapiens;SINGLE PROTEIN;CHEMBL3217727
CHEMBL3099077;9a;O=C(/C(=C/c1ccccc1)n1cncn1)c1ccc(F)cc1N1CCCCC1;Ka;3.89;10'-4L/mol;25706.94;Binding affinity to human serum albumin at 298 K by molecular spectroscopic analysis in presence of Mg2+;Serum albumin;Homo sapiens;SINGLE PROTEIN;CHEMBL3098086
CHEMBL2401877;5g;COc1ccc2cc3[n+](cc2c1OCCN(CCn1cncc1[N+](=O)[O-])Cc1ccc(F)cc1F)CCc1cc2c(cc1-3)OCO2.[Cl-];Ka;3.78;10'-4L/mol;26455.03;Binding affinity to human serum albumin assessed as effective quenching constant at pH 7.4 at 298K by modified Stern-Volmer method;Serum albumin;Homo sapiens;SINGLE PROTEIN;CHEMBL2401717
CHEMBL2312328;7a;COc1ccc2cc3[n+](cc2c1OCCN(CCn1cncn1)Cc1ccc(F)cc1F)CCc1cc2c(cc1-3)OCO2.[Cl-];Ka;3.74;10'-4L/mol;26737.97;Binding affinity to human serum albumin at pH 7.4 at 302 K by modified Stern-Volmer plot analysis;Serum albumin;Homo sapiens;SINGLE PROTEIN;CHEMBL3217727
CHEMBL4170702;5c;CC(=O)Nc1ccc(S(=O)(=O)Cc2nc3ccccc3n2Cc2ccc(F)cc2)cc1;Ka;3.69;10'-4L/mol;27100.27;Binding affinity to human serum albumin at 293 K by modified Stern-Volmer method;Serum albumin;Homo sapiens;SINGLE PROTEIN;CHEMBL4138085
CHEMBL3099077;9a;O=C(/C(=C/c1ccccc1)n1cncn1)c1ccc(F)cc1N1CCCCC1;Ka;3.64;10'-4L/mol;27472.53;Binding affinity to human serum albumin at pH 7.4 at 298 K by modified Stern-Volmer method;Serum albumin;Homo sapiens;SINGLE PROTEIN;CHEMBL3098086
CHEMBL3099077;9a;O=C(/C(=C/c1ccccc1)n1cncn1)c1ccc(F)cc1N1CCCCC1;Ka;3.64;10'-4L/mol;27472.53;Binding affinity to human serum albumin at 298 K by molecular spectroscopic analysis;Serum albumin;Homo sapiens;SINGLE PROTEIN;CHEMBL3098086
CHEMBL4170702;5c;CC(=O)Nc1ccc(S(=O)(=O)Cc2nc3ccccc3n2Cc2ccc(F)cc2)cc1;Ka;3.58;10'-4L/mol;27932.96;Binding affinity to human serum albumin at 313 K by modified Stern-Volmer method;Serum albumin;Homo sapiens;SINGLE PROTEIN;CHEMBL4138085
CHEMBL2312328;7a;COc1ccc2cc3[n+](cc2c1OCCN(CCn1cncn1)Cc1ccc(F)cc1F)CCc1cc2c(cc1-3)OCO2.[Cl-];Ka;3.51;10'-4L/mol;28490.03;Binding affinity to human serum albumin at pH 7.4 at 310 K by modified Stern-Volmer plot analysis;Serum albumin;Homo sapiens;SINGLE PROTEIN;CHEMBL3217727
CHEMBL3099077;9a;O=C(/C(=C/c1ccccc1)n1cncn1)c1ccc(F)cc1N1CCCCC1;Ka;3.49;10'-4L/mol;28653.30;Binding affinity to human serum albumin at 298 K by molecular spectroscopic analysis in presence of Cu2+;Serum albumin;Homo sapiens;SINGLE PROTEIN;CHEMBL3098086
CHEMBL3099077;9a;O=C(/C(=C/c1ccccc1)n1cncn1)c1ccc(F)cc1N1CCCCC1;Ka;3.34;10'-4L/mol;29940.12;Binding affinity to human serum albumin at 298 K by molecular spectroscopic analysis in presence of Zn2+;Serum albumin;Homo sapiens;SINGLE PROTEIN;CHEMBL3098086
CHEMBL3099077;9a;O=C(/C(=C/c1ccccc1)n1cncn1)c1ccc(F)cc1N1CCCCC1;Ka;3.23;10'-4L/mol;30959.75;Binding affinity to human serum albumin at 298 K by molecular spectroscopic analysis in presence of Ca2+;Serum albumin;Homo sapiens;SINGLE PROTEIN;CHEMBL3098086
CHEMBL2401877;5g;COc1ccc2cc3[n+](cc2c1OCCN(CCn1cncc1[N+](=O)[O-])Cc1ccc(F)cc1F)CCc1cc2c(cc1-3)OCO2.[Cl-];Ka;3.08;10'-4L/mol;32467.53;Binding affinity to human serum albumin assessed as effective quenching constant at pH 7.4 at 310K by modified Stern-Volmer method;Serum albumin;Homo sapiens;SINGLE PROTEIN;CHEMBL2401717
CHEMBL3099077;9a;O=C(/C(=C/c1ccccc1)n1cncn1)c1ccc(F)cc1N1CCCCC1;Ka;3.04;10'-4L/mol;32894.74;Binding affinity to human serum albumin at 298 K by molecular spectroscopic analysis in presence of Ni2+;Serum albumin;Homo sapiens;SINGLE PROTEIN;CHEMBL3098086
CHEMBL3099077;9a;O=C(/C(=C/c1ccccc1)n1cncn1)c1ccc(F)cc1N1CCCCC1;Ka;2.98;10'-4L/mol;33557.05;Binding affinity to human serum albumin at 298 K by molecular spectroscopic analysis in presence of Pb2+;Serum albumin;Homo sapiens;SINGLE PROTEIN;CHEMBL3098086
CHEMBL3099077;9a;O=C(/C(=C/c1ccccc1)n1cncn1)c1ccc(F)cc1N1CCCCC1;Ka;2.95;10'-4L/mol;33898.31;Binding affinity to human serum albumin at pH 7.4 at 310 K by modified Stern-Volmer method;Serum albumin;Homo sapiens;SINGLE PROTEIN;CHEMBL3098086
CHEMBL4218501;5q;CCOc1ccc2c(c1)sc1nc(-c3ccccc3)c(COCc3cn(Cc4ccc(Cl)c(Cl)c4)nn3)n12;Ka;2.63;10'-4L/mol;38022.81;Binding affinity to HSA assessed as modified Stern-Volmer quenching constant at pH 7.3 at 286 K by fluorescence assay;Serum albumin;Homo sapiens;SINGLE PROTEIN;CHEMBL4196079
CHEMBL4218501;5q;CCOc1ccc2c(c1)sc1nc(-c3ccccc3)c(COCc3cn(Cc4ccc(Cl)c(Cl)c4)nn3)n12;Ka;2.57;10'-4L/mol;38910.51;Binding affinity to HSA assessed as modified Stern-Volmer quenching constant at pH 7.3 at 303 K by fluorescence assay;Serum albumin;Homo sapiens;SINGLE PROTEIN;CHEMBL4196079
CHEMBL4279693;7d;Cc1ccc(-c2cc(-c3nc4ccccc4[nH]3)nc(N)n2)cc1;Ka;10.63;10'-4L/mol;9407.34;Binding affinity to HSA assessed as modified Stern-Volmer quenching constant at pH 7.4 at 284 K by fluorescence spectroscopic analysis;Serum albumin;Homo sapiens;SINGLE PROTEIN;CHEMBL4251572
CHEMBL4218501;5q;CCOc1ccc2c(c1)sc1nc(-c3ccccc3)c(COCc3cn(Cc4ccc(Cl)c(Cl)c4)nn3)n12;Ka;1.94;10'-4L/mol;51546.39;Binding affinity to HSA assessed as modified Stern-Volmer quenching constant at pH 7.3 at 310 K by fluorescence assay;Serum albumin;Homo sapiens;SINGLE PROTEIN;CHEMBL4196079
CHEMBL4159453;5g;CC(=O)Nc1ccc(S(=O)(=O)Cc2nc3ccccc3n2Cc2ccc(Cl)cc2Cl)cc1;Ka;1.11;10'-4L/mol;90090.09;Binding affinity to human serum albumin at 273 K by modified Stern-Volmer method;Serum albumin;Homo sapiens;SINGLE PROTEIN;CHEMBL4138085
CHEMBL4159453;5g;CC(=O)Nc1ccc(S(=O)(=O)Cc2nc3ccccc3n2Cc2ccc(Cl)cc2Cl)cc1;Ka;1.08;10'-4L/mol;92592.59;Binding affinity to human serum albumin at 293 K by modified Stern-Volmer method;Serum albumin;Homo sapiens;SINGLE PROTEIN;CHEMBL4138085
CHEMBL4159453;5g;CC(=O)Nc1ccc(S(=O)(=O)Cc2nc3ccccc3n2Cc2ccc(Cl)cc2Cl)cc1;Ka;1.06;10'-4L/mol;94339.62;Binding affinity to human serum albumin at 313 K by modified Stern-Volmer method;Serum albumin;Homo sapiens;SINGLE PROTEIN;CHEMBL4138085
CHEMBL1949756;23;Cc1cc2c(c(O)c1-c1c(C)cc3c(c1O)/C(=C/NCCCCCC(=O)[O-])C(=O)C(O)=C3C(C)C)/C(=C/NCCCCCC(=O)[O-])C(=O)C(O)=C2C(C)C.[Na+].[Na+];Ka;3.22;10'4L/mol;31055.90;Binding affinity to human serum albumin by fluorescence quenching assay;Serum albumin;Homo sapiens;SINGLE PROTEIN;CHEMBL1949531
CHEMBL1949746;13;Cc1cc2c(c(O)c1-c1c(C)cc3c(c1O)/C(=C/N[C@@H](Cc1c[nH]c4ccccc14)C(=O)[O-])C(=O)C(O)=C3C(C)C)/C(=C/N[C@@H](Cc1c[nH]c3ccccc13)C(=O)[O-])C(=O)C(O)=C2C(C)C.[Na+].[Na+];Ka;9275.00;10'4L/mol;10.78;Binding affinity to human serum albumin by fluorescence quenching assay;Serum albumin;Homo sapiens;SINGLE PROTEIN;CHEMBL1949531
CHEMBL1949754;21;Cc1cc2c(c(O)c1-c1c(C)cc3c(c1O)/C(=C/N[C@@H](Cc1ccc(O)cc1)C(=O)[O-])C(=O)C(O)=C3C(C)C)/C(=C/N[C@@H](Cc1ccc(O)cc1)C(=O)[O-])C(=O)C(O)=C2C(C)C.[Na+].[Na+];Ka;7535.00;10'4L/mol;13.27;Binding affinity to human serum albumin by fluorescence quenching assay;Serum albumin;Homo sapiens;SINGLE PROTEIN;CHEMBL1949531
CHEMBL1949743;10;Cc1cc2c(c(O)c1-c1c(C)cc3c(c1O)/C(=C/N[C@@H](Cc1c[nH]cn1)C(=O)[O-])C(=O)C(O)=C3C(C)C)/C(=C/N[C@@H](Cc1c[nH]cn1)C(=O)[O-])C(=O)C(O)=C2C(C)C.[Na+].[Na+];Ka;6721.00;10'4L/mol;14.88;Binding affinity to human serum albumin by fluorescence quenching assay;Serum albumin;Homo sapiens;SINGLE PROTEIN;CHEMBL1949531
CHEMBL1952323;7;Cc1cc2c(c(O)c1-c1c(C)cc3c(c1O)/C(=C/N[C@@H](CO)C(=O)[O-])C(=O)C(O)=C3C(C)C)/C(=C/N[C@@H](CO)C(=O)[O-])C(=O)C(O)=C2C(C)C.[Na+].[Na+];Ka;5776.00;10'4L/mol;17.31;Binding affinity to human serum albumin by fluorescence quenching assay;Serum albumin;Homo sapiens;SINGLE PROTEIN;CHEMBL1949531
CHEMBL1949750;17;CC[C@H](C)[C@H](N/C=C1\C(=O)C(O)=C(C(C)C)c2cc(C)c(-c3c(C)cc4c(c3O)/C(=C/N[C@H](C(=O)[O-])[C@@H](C)CC)C(=O)C(O)=C4C(C)C)c(O)c21)C(=O)[O-].[Na+].[Na+];Ka;5322.00;10'4L/mol;18.79;Binding affinity to human serum albumin by fluorescence quenching assay;Serum albumin;Homo sapiens;SINGLE PROTEIN;CHEMBL1949531
CHEMBL1952321;4;COC(=O)C(N/C=C1\C(=O)C(O)=C(C(C)C)c2cc(C)c(-c3c(C)cc4c(c3O)/C(=C/NC(C(=O)OC)c3ccccc3)C(=O)C(O)=C4C(C)C)c(O)c21)c1ccccc1;Ka;4266.00;10'4L/mol;23.44;Binding affinity to human serum albumin by fluorescence quenching assay;Serum albumin;Homo sapiens;SINGLE PROTEIN;CHEMBL1949531
CHEMBL1949757;24;Cc1cc2c(c(O)c1-c1c(C)cc3c(c1O)/C(=C/NCCCCCCCC(=O)[O-])C(=O)C(O)=C3C(C)C)/C(=C/NCCCCCCCC(=O)[O-])C(=O)C(O)=C2C(C)C.[Na+].[Na+];Ka;2863.00;10'4L/mol;34.93;Binding affinity to human serum albumin by fluorescence quenching assay;Serum albumin;Homo sapiens;SINGLE PROTEIN;CHEMBL1949531
CHEMBL1949755;22;Cc1cc2c(c(O)c1-c1c(C)cc3c(c1O)/C(=C/NCCCCC(=O)[O-])C(=O)C(O)=C3C(C)C)/C(=C/NCCCCC(=O)[O-])C(=O)C(O)=C2C(C)C.[Na+].[Na+];Ka;2429.00;10'4L/mol;41.17;Binding affinity to human serum albumin by fluorescence quenching assay;Serum albumin;Homo sapiens;SINGLE PROTEIN;CHEMBL1949531
CHEMBL1949752;19;Cc1cc2c(c(O)c1-c1c(C)cc3c(c1O)/C(=C/NC(C(=O)[O-])c1ccc(O)cc1)C(=O)C(O)=C3C(C)C)/C(=C/NC(C(=O)[O-])c1ccc(O)cc1)C(=O)C(O)=C2C(C)C.[Na+].[Na+];Ka;2161.00;10'4L/mol;46.27;Binding affinity to human serum albumin by fluorescence quenching assay;Serum albumin;Homo sapiens;SINGLE PROTEIN;CHEMBL1949531
CHEMBL450352;8;Cc1cc2c(c(O)c1-c1c(C)cc3c(c1O)/C(=C/NCCS(=O)(=O)[O-])C(=O)C(O)=C3C(C)C)/C(=C/NCCS(=O)(=O)[O-])C(=O)C(O)=C2C(C)C.[Na+].[Na+];Ka;1756.00;10'4L/mol;56.95;Binding affinity to human serum albumin by fluorescence quenching assay;Serum albumin;Homo sapiens;SINGLE PROTEIN;CHEMBL1949531
CHEMBL1949751;18;Cc1cc2c(c(O)c1-c1c(C)cc3c(c1O)/C(=C/N[C@H](C(=O)[O-])c1ccccc1)C(=O)C(O)=C3C(C)C)/C(=C/N[C@H](C(=O)[O-])c1ccccc1)C(=O)C(O)=C2C(C)C.[Na+].[Na+];Ka;1401.00;10'4L/mol;71.38;Binding affinity to human serum albumin by fluorescence quenching assay;Serum albumin;Homo sapiens;SINGLE PROTEIN;CHEMBL1949531
CHEMBL1952322;6;Cc1cc2c(c(O)c1-c1c(C)cc3c(c1O)/C(=C/N[C@@H](CC(C)C)C(=O)[O-])C(=O)C(O)=C3C(C)C)/C(=C/N[C@@H](CC(C)C)C(=O)[O-])C(=O)C(O)=C2C(C)C.[Na+].[Na+];Ka;1348.00;10'4L/mol;74.18;Binding affinity to human serum albumin by fluorescence quenching assay;Serum albumin;Homo sapiens;SINGLE PROTEIN;CHEMBL1949531
CHEMBL1949753;20;Cc1cc2c(c(O)c1-c1c(C)cc3c(c1O)/C(=C/NC(C(=O)[O-])c1ccc(Cl)cc1)C(=O)C(O)=C3C(C)C)/C(=C/NC(C(=O)[O-])c1ccc(Cl)cc1)C(=O)C(O)=C2C(C)C.[Na+].[Na+];Ka;1287.00;10'4L/mol;77.70;Binding affinity to human serum albumin by fluorescence quenching assay;Serum albumin;Homo sapiens;SINGLE PROTEIN;CHEMBL1949531
CHEMBL1949745;12;Cc1cc2c(c(O)c1-c1c(C)cc3c(c1O)/C(=C/NCC(=O)[O-])C(=O)C(O)=C3C(C)C)/C(=C/NCC(=O)[O-])C(=O)C(O)=C2C(C)C.[Na+].[Na+];Ka;1246.00;10'4L/mol;80.26;Binding affinity to human serum albumin by fluorescence quenching assay;Serum albumin;Homo sapiens;SINGLE PROTEIN;CHEMBL1949531
CHEMBL1952318;1;COC(=O)[C@H](C)N/C=C1\C(=O)C(O)=C(C(C)C)c2cc(C)c(-c3c(C)cc4c(c3O)/C(=C/N[C@@H](C)C(=O)OC)C(=O)C(O)=C4C(C)C)c(O)c21;Ka;1041.00;10'4L/mol;96.06;Binding affinity to human serum albumin by fluorescence quenching assay;Serum albumin;Homo sapiens;SINGLE PROTEIN;CHEMBL1949531
CHEMBL1630;AQ;CCN(CC)Cc1cc(Nc2ccnc3cc(Cl)ccc23)ccc1O.Cl;Ka;8.39;10'-4/M;11918.95;Binding affinity to human serum albumin assessed as modified Stern-Volmer association constant at pH 7.4 and 301K by spectrofluorimetry;Serum albumin;Homo sapiens;SINGLE PROTEIN;CHEMBL2057110
CHEMBL1630;AQ;CCN(CC)Cc1cc(Nc2ccnc3cc(Cl)ccc23)ccc1O.Cl;Ka;7.31;10'-4/M;13679.89;Binding affinity to human serum albumin assessed as modified Stern-Volmer association constant at pH 7.4 and 291K by spectrofluorimetry in presence of warfarin;Serum albumin;Homo sapiens;SINGLE PROTEIN;CHEMBL2057110
CHEMBL1630;AQ;CCN(CC)Cc1cc(Nc2ccnc3cc(Cl)ccc23)ccc1O.Cl;Ka;4.59;10'-4/M;21786.49;Binding affinity to human serum albumin assessed as modified Stern-Volmer association constant at pH 7.4 and 310K by spectrofluorimetry;Serum albumin;Homo sapiens;SINGLE PROTEIN;CHEMBL2057110
CHEMBL1630;AQ;CCN(CC)Cc1cc(Nc2ccnc3cc(Cl)ccc23)ccc1O.Cl;Ka;13.8;10'-4/M;7246.38;Binding affinity to human serum albumin assessed as modified Stern-Volmer association constant at pH 7.4 and 291K by spectrofluorimetry;Serum albumin;Homo sapiens;SINGLE PROTEIN;CHEMBL2057110
CHEMBL1630;AQ;CCN(CC)Cc1cc(Nc2ccnc3cc(Cl)ccc23)ccc1O.Cl;Ka;11.36;10'-4/M;8802.82;Binding affinity to human serum albumin assessed as modified Stern-Volmer association constant at pH 7.4 and 291K by spectrofluorimetry in presence of ibuprofen;Serum albumin;Homo sapiens;SINGLE PROTEIN;CHEMBL2057110
CHEMBL585569;QT;Cc1nc2ccccc2c(C(=O)OC2CC(C)(C)N(O)C(C)(C)C2)c1O;Ka;9.0;10'4/M;11111.11;Binding affinity to human serum albumin by tryptophan fluorescence quenching method;Serum albumin;Homo sapiens;SINGLE PROTEIN;CHEMBL1156087
CHEMBL1450;ATO;O=C1C(O)=C([C@H]2CC[C@H](c3ccc(Cl)cc3)CC2)C(=O)c2ccccc21;Ka;7.15;10'4/M;13986.01;Binding affinity to human serum albumin at 845 uM using 33.8 uM HSA and 14 mM phosphate and 30% DMF at pH 7.4 and 25 degC by fluorescence spectroscopy;Serum albumin;Homo sapiens;SINGLE PROTEIN;CHEMBL3580619
CHEMBL570674;C343T;CC1(C)CC(OC(=O)c2cc3cc4c5c(c3oc2=O)CCCN5CCC4)CC(C)(C)N1O;Ka;5.0;10'4/M;20000.00;Binding affinity to human serum albumin by tryptophan fluorescence quenching method;Serum albumin;Homo sapiens;SINGLE PROTEIN;CHEMBL1156087
CHEMBL570674;C343T;CC1(C)CC(OC(=O)c2cc3cc4c5c(c3oc2=O)CCCN5CCC4)CC(C)(C)N1O;Ka;4.8;10'4/M;20833.33;Binding affinity to human serum albumin by Benesi-Hildebrand method;Serum albumin;Homo sapiens;SINGLE PROTEIN;CHEMBL1156087
CHEMBL4529234;9g;COc1ccc(Cn2cc(C(=O)N/N=C3/C(=O)Nc4c(C)cccc43)nn2)cc1;Ka;1.27;10'4/M;78740.16;Binding affinity to HSA by ITC;Serum albumin;Homo sapiens;SINGLE PROTEIN;CHEMBL4411296
CHEMBL1949742;9;Cc1cc2c(c(O)c1-c1c(C)cc3c(c1O)/C(=C/N[C@@H](CS)C(=O)[O-])C(=O)C(O)=C3C(C)C)/C(=C/N[C@@H](CS)C(=O)[O-])C(=O)C(O)=C2C(C)C.[Na+].[Na+];Ka;8202.00;10'3L/mol;121.92;Binding affinity to human serum albumin by fluorescence quenching assay;Serum albumin;Homo sapiens;SINGLE PROTEIN;CHEMBL1949531
CHEMBL1952320;3;COC(=O)[C@H](CC(C)C)N/C=C1\C(=O)C(O)=C(C(C)C)c2cc(C)c(-c3c(C)cc4c(c3O)/C(=C/N[C@@H](CC(C)C)C(=O)OC)C(=O)C(O)=C4C(C)C)c(O)c21;Ka;7124.00;10'3L/mol;140.37;Binding affinity to human serum albumin by fluorescence quenching assay;Serum albumin;Homo sapiens;SINGLE PROTEIN;CHEMBL1949531
CHEMBL575507;5;COC(=O)[C@H](Cc1c[nH]c2ccccc12)N/C=C1\C(=O)C(O)=C(C(C)C)c2cc(C)c(-c3c(C)cc4c(c3O)/C(=C/N[C@@H](Cc3c[nH]c5ccccc35)C(=O)OC)C(=O)C(O)=C4C(C)C)c(O)c21;Ka;2262.00;10'3L/mol;442.09;Binding affinity to human serum albumin by fluorescence quenching assay;Serum albumin;Homo sapiens;SINGLE PROTEIN;CHEMBL1949531
CHEMBL1952319;2;CCOC(=O)CN/C=C1\C(=O)C(O)=C(C(C)C)c2cc(C)c(-c3c(C)cc4c(c3O)/C(=C/NCC(=O)OCC)C(=O)C(O)=C4C(C)C)c(O)c21;Ka;1903.00;10'2L/mol;5254.86;Binding affinity to human serum albumin by fluorescence quenching assay;Serum albumin;Homo sapiens;SINGLE PROTEIN;CHEMBL1949531
CHEMBL298470;TFQ, tafenoquine;COc1cc(C)c2c(Oc3cccc(C(F)(F)F)c3)c(OC)cc(NC(C)CCCN)c2n1;Ka;3.0;10^5/M;3333.33;Binding affinity to human serum albumin on sepharose column by affinity chromatography;Serum albumin;Homo sapiens;SINGLE PROTEIN;CHEMBL1145548
CHEMBL298470;TFQ, tafenoquine;COc1cc(C)c2c(Oc3cccc(C(F)(F)F)c3)c(OC)cc(NC(C)CCCN)c2n1;Ka;3.0;10^5/M;3333.33;Binding affinity to human serum albumin by fluorescence emission spectra;Serum albumin;Homo sapiens;SINGLE PROTEIN;CHEMBL1145548
CHEMBL12;diazepam;CN1C(=O)CN=C(c2ccccc2)c2cc(Cl)ccc21;Ka;1.8;10^5/M;5555.56;Binding affinity to human serum albumin on sepharose column by affinity chromatography;Serum albumin;Homo sapiens;SINGLE PROTEIN;CHEMBL1145548
CHEMBL298470;TFQ, tafenoquine;COc1cc(C)c2c(Oc3cccc(C(F)(F)F)c3)c(OC)cc(NC(C)CCCN)c2n1;Ka;2.4;10^4M;41666.67;Binding affinity to human serum albumin by circular dichroism and UV/VIS spectroscopic method;Serum albumin;Homo sapiens;SINGLE PROTEIN;CHEMBL1145548
CHEMBL1630;AMQ, amodiaquine;CCN(CC)Cc1cc(Nc2ccnc3cc(Cl)ccc23)ccc1O.Cl;Ka;0.62;10^4M;161290.32;Binding affinity to human serum albumin by circular dichroism and UV/VIS spectroscopic method;Serum albumin;Homo sapiens;SINGLE PROTEIN;CHEMBL1145548
CHEMBL259746;(S)-oxazepam acetate;CC(=O)O[C@@H]1N=C(c2ccccc2)c2cc(Cl)ccc2NC1=O;Ka;8.0;10^4/M;12500.00;Binding affinity to human serum albumin on sepharose column by affinity chromatography;Serum albumin;Homo sapiens;SINGLE PROTEIN;CHEMBL1145548
CHEMBL416956;MFQ, mefloquine;OC(c1cc(C(F)(F)F)nc2c(C(F)(F)F)cccc12)C1CCCCN1;Ka;8.0;10^4/M;12500.00;Binding affinity to human serum albumin on sepharose column by affinity chromatography;Serum albumin;Homo sapiens;SINGLE PROTEIN;CHEMBL1145548
CHEMBL408226;(S)-lorazepam acetate;CC(=O)O[C@@H]1N=C(c2ccccc2Cl)c2cc(Cl)ccc2NC1=O;Ka;4.0;10^4/M;25000.00;Binding affinity to human serum albumin on sepharose column by affinity chromatography;Serum albumin;Homo sapiens;SINGLE PROTEIN;CHEMBL1145548
CHEMBL259541;(R)-lorazepam acetate;CC(=O)O[C@H]1N=C(c2ccccc2Cl)c2cc(Cl)ccc2NC1=O;Ka;2.0;10^4/M;50000.00;Binding affinity to human serum albumin on sepharose column by affinity chromatography;Serum albumin;Homo sapiens;SINGLE PROTEIN;CHEMBL1145548
CHEMBL1630;AMQ, amodiaquine;CCN(CC)Cc1cc(Nc2ccnc3cc(Cl)ccc23)ccc1O.Cl;Ka;2.0;10^4/M;50000.00;Binding affinity to human serum albumin on sepharose column by affinity chromatography;Serum albumin;Homo sapiens;SINGLE PROTEIN;CHEMBL1145548
CHEMBL411064;(R)-oxazepam acetate;CC(=O)O[C@H]1N=C(c2ccccc2)c2cc(Cl)ccc2NC1=O;Ka;1.0;10^4/M;100000.00;Binding affinity to human serum albumin on sepharose column by affinity chromatography;Serum albumin;Homo sapiens;SINGLE PROTEIN;CHEMBL1145548
CHEMBL7568;QR;CCN(CC)CCCC(C)Nc1c2ccc(Cl)cc2nc2ccc(OC)cc12;Ka;7.0;10^3/M;142857.14;Binding affinity to human serum albumin on sepharose column by affinity chromatography;Serum albumin;Homo sapiens;SINGLE PROTEIN;CHEMBL1145548
CHEMBL506;PRQ, primaquine;COc1cc(NC(C)CCCN)c2ncccc2c1;Ka;7.0;10^3/M;142857.14;Binding affinity to human serum albumin on sepharose column by affinity chromatography;Serum albumin;Homo sapiens;SINGLE PROTEIN;CHEMBL1145548
CHEMBL76;CQ;CCN(CC)CCCC(C)Nc1ccnc2cc(Cl)ccc12;Ka;2.0;10^3/M;500000000.00;Binding affinity to human serum albumin on sepharose column by affinity chromatography;Serum albumin;Homo sapiens;SINGLE PROTEIN;CHEMBL1145548
CHEMBL65061;Leukotriene B4;CCCCC/C=C\C[C@@H](O)/C=C/C=C/C=C\[C@@H](O)CCCC(=O)O;Ka;67000.0;1/M;14.93;"In vitro Ka value against human serum albumin; N=1";Serum albumin;Homo sapiens;SINGLE PROTEIN;CHEMBL1142776
